Mgr. Dalibor Blažek, Ph.D.
Research Group Leader Senior, Dalibor Blažek Research Group
office: bldg. E35/261
Kamenice 753/5
625 00 Brno
phone: | +420 549 49 7564 |
---|---|
e‑mail: |
social and academic networks: |
---|
-
MSCAfellow7_MUNI (CZ.02.01.01/00/22_010/0008854)
MU Researcher: Ing. Lukáš Palko MU Faculty or unit: Rector's Office Project Period: 6/2024 — 6/2028Investor: Ministry of Education, Youth and Sports of the CR / OP JAK -
Identification and characterization of a new pathway regulating pre-mRNA splicing (GX23-04754X)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 1/2023 — 12/2027Investor: Czech Science Foundation / EXPRO -
Pokročilá preklinická optimalizace a charakterizace nových inhibitorů kinázy CDK11 pro moderní protinádorovou terapii (MUNI/31/01202404/2024)
MU Researcher: doc. Mgr. Kamil Paruch, Ph.D. MU Faculty or unit: Faculty of Science Project Period: 1/2025 — 12/2026Investor: Masaryk University / Internal projects of TTO -
Development and use of CDK11 inhibitors for pilot characterization of the novel anti-cancer target (MUNI/G/1129/2021)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 4/2022 — 12/2024Investor: Masaryk University / Grant Agency of Masaryk University -
DIANA panel for testing of selectivity of inhibitors of clinically relevant protein kinases and its application in the drug discovery market. Preclinical development of new inhibitors of CDK11 - key enzyme for growth of cancer cells. (FW03010138)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 1/2021 — 12/2024Investor: Technology Agency of the Czech Republic / TREND -
Characterization of kinase activity of cyclin-dependent kinase 11 (CDK11), an essential enzyme for the growth of cancer (GA21-19266S)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 1/2021 — 12/2023Investor: Czech Science Foundation / Standard Projects -
CDK12 controls G1/S progression by regulating RNAPII processivity at core DNA replication genes (MUNI/E/0514/2019)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 6/2019 — 5/2020Investor: Masaryk University / Grant Agency of Masaryk University -
Charakterization of a new factor in regulation of transcription/mRNA processing of histone genes (MUNI/E/0990/2018)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 10/2018 — 10/2019Investor: Masaryk University / Grant Agency of Masaryk University -
Characterization of novel substrates and function for ovarian cancer-related cyclin-dependent kinase 12 (Cdk12) (GA17-13692S)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 1/2017 — 12/2019Investor: Czech Science Foundation / Standard Projects -
Regulace genové exprese novým faktorem vázajícím mRNA (GA16-10930S)
MU Researcher: Mgr. Dalibor Blažek, Ph.D. MU Faculty or unit: Central European Institute of Technology Project Period: 1/2016 — 12/2018Investor: Czech Science Foundation / Standard Projects